Molecular Miners Find Pain Relief Drugs From The Sea
10/19/2005 5:08:52 PM
A cone snail toxin discovered by Melbourne researchers has proven to have great potential for easing pain and could provide an improved treatment for neuropathic pain associated with diabetes.
Melbourne based company Metabolic Pharmaceuticals Limited recently announced successful results in preclinical trials of the toxin. The company will begin clinical trials in humans this month to firstly test the safety of the toxin in normal males, and later its effectiveness in treating the neuropathic pain associated with diabetes.
From the University of Melbourne’s Department of Biochemistry and Molecular Biology and the recently launched Bio21 Institute, Associate Professor Bruce Livett says the toxin – called ACV1 – also has potential for treating a range of other painful conditions, such as multiple sclerosis, shingles and sciatica.
comments powered by